Vetr Issues Strong Buy As Teva Trends Down By: Benzinga via Benzinga May 19, 2017 at 07:30 AM EDT The Vetr crowd on Thursday upgraded its rating for Teva Pharmaceutical Industries Limited (ADR) (NYSE: TEVA) from 3.5 stars (Buy), ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR